Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: November 29, 2022 Report Code: GDME1482EPD-ST

Select Item

The clinical chemistry segment comprises reagents, test kits, and electrodes. This aid in determining the concentration or activity of biomolecules, such as proteins, carbohydrates, lipids, enzymes, minerals, or other small molecules. These biomolecules could be easily collected via body fluids such as blood, serum or plasma, and urine.

The clinical chemistry pipeline market research report provides comprehensive information about the clinical chemistry pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Clinical Chemistry Pipeline Products Market Segments

The key segments in the clinical chemistry pipeline products market are Therapeutic Drug Monitoring, Clinical Chemistry Rapid Tests & POC, Immunosuppressant Therapeutic Drug Monitoring, Antibiotic/Antivirus Therapeutic Drug Monitoring, Central Nervous Systems Therapeutic Drug Monitoring, Urine Analyzers, and Cardiovascular Therapeutic Drug Monitoring among others. Therapeutic Drug Monitoring has the highest number of products in the clinical chemistry pipeline products market.

Clinical Chemistry Pipeline Products Market Analysis by Segments, 2022 (%)

Clinical Chemistry Pipeline Products Market Analysis by SegmentsFor more insights into the clinical chemistry pipeline products market segments, download a free report sample

Clinical Chemistry Pipeline Products Market Segmentation by Territories

Some of the key territories with clinical chemistry products in the pipeline are the United States, Europe, Global, South Korea, China, the United Kingdom, Australia, Canada, Japan, and Singapore among others. As of November 2022, the US has the highest number of products in the pipeline out of them all.

Clinical Chemistry Pipeline Products Market Analysis, by Territories, 2022 (%)

Clinical Chemistry Pipeline Products Market Analysis, by Territories

For more territory insights into the clinical chemistry pipeline products market, download a free report sample

Clinical Chemistry Pipeline Products Market Segmentation by Regulatory Paths

Some of the key regulatory paths followed by the clinical chemistry pipeline products market are 510(k), CE-IVD, MDITAC, NMPA, ICAC, UKCA, MDL, TGA, Ninsho, HSA, and CE among others. Most of the products follow the 510(k) pathway to enter the market.

Clinical Chemistry Pipeline Products Market Analysis, by Regulatory Paths, 2022 (%)

Clinical Chemistry Pipeline Products Market Analysis, by Regulatory Paths

For more clinical chemistry pipeline products regulatory path insights, download a free report sample

Clinical Chemistry Pipeline Products Market - Competitive Landscape

Some of the leading companies in the clinical chemistry pipeline products market are 20/20 GeneSystems Inc, 4basebio AG, A.Menarini Diagnostics Ltd, A/C Diagnostics LLC, Abbott Diagnostics, Abreos Biosciences Inc (Inactive), Acetaminophen Toxicity Diagnostics, LLC, ADA Technologies, Inc., Adaptive Biotechnologies Corp, and Advanced Biological Laboratories SA among others.

Clinical Chemistry Pipeline Products Market Report Overview

Key Segments Therapeutic Drug Monitoring, Clinical Chemistry Rapid Tests & POC, Immunosuppressant Therapeutic Drug Monitoring, Antibiotic/Antivirus Therapeutic Drug Monitoring, Central Nervous Systems Therapeutic Drug Monitoring, Urine Analyzers, and Cardiovascular Therapeutic Drug Monitoring
Analysis Year 2022
Key Territories The United States, Europe, Global, South Korea, China, The United Kingdom, Australia, Canada, Japan, and Singapore
Key Regulatory Paths 510(k), CE-IVD, MDITAC, NMPA, ICAC, UKCA, MDL, TGA, Ninsho, HSA, and CE
Leading Companies 20/20 GeneSystems Inc, 4basebio AG, A.Menarini Diagnostics Ltd, A/C Diagnostics LLC, Abbott Diagnostics, Abreos Biosciences Inc (Inactive), Acetaminophen Toxicity Diagnostics, LLC, ADA Technologies, Inc., Adaptive Biotechnologies Corp, and Advanced Biological Laboratories SA

Clinical Chemistry Pipeline Products Market Segments Outlook (2022)

  • Therapeutic Drug Monitoring
  • Clinical Chemistry Rapid Tests & POC
  • Immunosuppressant Therapeutic Drug Monitoring
  • Antibiotic/Antivirus Therapeutic Drug Monitoring
  • Central Nervous Systems Therapeutic Drug Monitoring
  • Urine Analyzers
  • Cardiovascular Therapeutic Drug Monitoring

Clinical Chemistry Pipeline Products Market Territories Outlook (2022)

  • The United States
  • Europe
  • Global
  • South Korea
  • China
  • The United Kingdom
  • Australia
  • Canada
  • Japan
  • Singapore

Clinical Chemistry Pipeline Products Market Regulatory Paths Outlook (2022)

  • 510(k)
  • CE-IVD
  • MDITAC
  • NMPA
  • ICAC
  • UKCA
  • MDL
  • TGA
  • Ninsho
  • HAS
  • CE

Scope

This report provides:

  • Extensive coverage of the clinical chemistry under development.

  • Details of major clinical chemistry pipeline products which include product description, licensing, collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

  • Reviews of the major players involved in the development of clinical chemistry and list all their pipeline projects.

  • The coverage of clinical chemistry pipeline products based on various stages of development ranging from early development to the approved/issued stage.

  • Key clinical trial data of ongoing trials specific to clinical chemistry pipeline products.

  • Recent Developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.

  • Identify and understand important and diverse types of clinical chemistry under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

20/20 GeneSystems Inc
4basebio AG
A.Menarini Diagnostics Ltd
A/C Diagnostics LLC
Abbott Diagnostics
Abreos Biosciences Inc (Inactive)
Acetaminophen Toxicity Diagnostics, LLC
ADA Technologies, Inc.
Adaptive Biotechnologies Corp
Advanced Biological Laboratories SA
Affinergy LLC
Alfa Wassermann Diagnostic Technologies, LLC
Alfa Wassermann Inc
Am Biotechnologies, LLC
Analyticon Biotechnologies AG
AnaZyme LLC
Angle Biosciences Inc
Animated Dynamics Inc
Ap Lifesciences LLC
Applied Research using OMIC Sciences SL
Arizona State University
ARK Diagnostics Inc
Augurix SA
AutoGenomics Inc
Avacta Group Plc
Base Pair Biotechnologies Inc
Becton Dickinson and Co
BG Medicine Inc
Biocross SL
Bioftalmik Applied Research
BIOHOPE Scientific SL
BioMarin Pharmaceutical Inc
Biotech Resources Aust Pty Ltd
Bisu Inc
Boditech Med Inc
Boston University
Burnet Institute
California Pacific Medical Center Research Institute
Calmark Sweden AB
Cambridge Diagnostic Imaging Ltd
Carclo Diagnostic Solutions Ltd
CardioGenics Inc
CCC Diagnostics LLC
Cellavision AB
Cellex Inc
Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
Centre Hospitalier Universitaire de Nice
Charite University Hospital of Berlin
Chemeleon Inc
China Sky One Medical Inc
Chromanostics Inc
Chronix Biomedical Inc
Claremont BioSolutions
Clemson University
Clinical Design Technologies Ltd
Cognizance Biomarkers LLC
Columbia University
ContraVac Inc (Inactive)
CytoVas LLC
Denovo Biolabs Pvt Ltd
DiaSys Diagnostic Systems GmbH
DNAPrint Genomics Inc (Inactive)
DoacLevel
Dublin City University
Ecole Polytechnique Federale de Lausanne
Edan Instruments Inc
EKF Diagnostics Holdings Plc
ELITechGroup Inc
Eurobio Scientific SA
First Light Diagnostics Inc
Fluoresprobe Sciences LLC
Foundation for Innovative New Diagnostics
Gene Express, Inc. (Inactive)
GenMark Diagnostics Inc
Giner Inc
GlucoSentient Inc
Group K Diagnostics
Guangzhou Wondfo Biotech Co Ltd
Healthmed Services Ltd. (Inactive)
Healthy io Ltd
Horiba Ltd
Imperial College London
Indian Institute of Technology Delhi
Inflammatix Inc
Insilixa, Inc.
Instrumentation Laboratory Co
IPI Singapore
IR2Dx Inc.
IRIS International Inc
iXensor Co. Ltd.
Johns Hopkins University
Kalium Health Ltd
KIYATEC Inc
Kobe University
Kwandong University College of Medicine
Laboratorios Rubio SA
LifeAssays AB
LumiraDx Ltd
Magee-Womens Research Institute
Massachusetts Institute of Technology
Medibio Ltd
Medical Research Council
Medical University of South Carolina
Metabolon Inc
Miami VA Healthcare System
MiCo BioMed Co Ltd
Monash University
Montana State University
Mylab Discovery Solutions Pvt Ltd
Myotherapeutics LLC (Inactive)
NanoSpeed Diagnostics Inc
Newcastle University
Nipro Europe N.V.
Northeastern University
NTBIO Diagnostics Inc
Nuclea Biotechnologies Inc. (Inactive)
Ohmx Corp
OPKO Health Inc
Overture Life Inc
Oxford Immunotec Ltd
Pax Neuroscience Inc
Pelago Bioscience AB
Pennsylvania State University
Plateletdiagnostics LLC
PortaScience Inc
Prediction Sciences LLC (Inactive)
ProciseDx LLC
Progenika Biopharma SA
PrognosDx Health Inc
Proteomika (Inactive)
Purdue University
QSTAG Co Ltd
Queen Mary University of London
Quidel Corp
redhot diagnostics AB
Roche Diagnostics Corp
Roche Diagnostics International Ltd
Rockland Immunochemicals Inc
SAGA Diagnostics AB
Saladax Biomedical Inc
SaltCheck Inc (Inactive)
Seattle Children's Hospital
Sebia SA
SenGenix Inc
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Siemens Healthcare Diagnostics Inc
Sirius Genomics Inc
Spanish National Research Council
Specto Srl
SQI Diagnostics Inc
Stanford University
SuperNova Diagnostics, Inc.
Systagenix Wound Management Ltd
T2 Biosystems Inc
Teco Diagnostics
Testcard Diagnostics Ltd
The Chinese University of Hong Kong
The University of New South Wales press Limited
TheraDiag SA
Thermo Fisher Scientific Inc
U.S. Army Medical Research and Development Command
Universal Biosensors Inc
Universidade Feevale
University of Central Florida
University of Colorado
University of Colorado Denver
University of Edinburgh
University of Florida
University of Illinois at Chicago
University of Kentucky
University of Massachusetts Lowell
University of North Carolina at Chapel Hill
University of North Dakota
University of Queensland
University of South Australia
University of Texas at Arlington
University of Washington
UrSure Inc
Vanderbilt University
Vanteres Pte Ltd
Virginia Polytechnic Institute and State University
Vyant Bio Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 17

|1.2 List of Figures 35

2 Introduction 36

2.1 Clinical Chemistry Overview 36

3 Products under Development 37

3.1 Clinical Chemistry – Pipeline Products by Stage of Development 37

3.2 Clinical Chemistry – Pipeline Products by Segment 38

3.3 Clinical Chemistry – Pipeline Products by Territory 40

3.4 Clinical Chemistry – Pipeline Products by Regulatory Path 42

3.5 Clinical Chemistry – Pipeline Products by Estimated Approval Date 43

3.6 Clinical Chemistry – Ongoing Clinical Trials 44

4 Clinical Chemistry – Pipeline Products under Development by Companies 45

4.1 Clinical Chemistry Companies – Pipeline Products by Stage of Development 45

4.2 Clinical Chemistry – Pipeline Products by Stage of Development 52

5 Clinical Chemistry Companies and Product Overview 62

5.1 20/20 GeneSystems Inc Company Overview 62

5.1.1 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.2 4basebio AG Company Overview 63

5.2.1 4basebio AG Pipeline Products & Ongoing Clinical Trials Overview 63

5.3 A.Menarini Diagnostics Ltd Company Overview 64

5.3.1 A.Menarini Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.4 A/C Diagnostics LLC Company Overview 65

5.4.1 A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.5 Abbott Diagnostics Company Overview 66

5.5.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 66

5.6 Abreos Biosciences Inc (Inactive) Company Overview 70

5.6.1 Abreos Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 70

5.7 Acetaminophen Toxicity Diagnostics, LLC Company Overview 78

5.7.1 Acetaminophen Toxicity Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 78

5.8 ADA Technologies, Inc. Company Overview 81

5.8.1 ADA Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81

5.9 Adaptive Biotechnologies Corp Company Overview 82

5.9.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 82

5.10 Advanced Biological Laboratories SA Company Overview 83

5.10.1 Advanced Biological Laboratories SA Pipeline Products & Ongoing Clinical Trials Overview 83

5.11 Affinergy LLC Company Overview 85

5.11.1 Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview 85

5.12 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 89

5.12.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 89

5.13 Alfa Wassermann Inc Company Overview 91

5.13.1 Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.14 Am Biotechnologies, LLC Company Overview 92

5.14.1 Am Biotechnologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 92

5.15 Analyticon Biotechnologies AG Company Overview 94

5.15.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 94

5.16 AnaZyme LLC Company Overview 97

5.16.1 AnaZyme LLC Pipeline Products & Ongoing Clinical Trials Overview 97

5.17 Angle Biosciences Inc Company Overview 99

5.17.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.18 Animated Dynamics Inc Company Overview 100

5.18.1 Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.19 Ap Lifesciences LLC Company Overview 103

5.19.1 Ap Lifesciences LLC Pipeline Products & Ongoing Clinical Trials Overview 103

5.20 Applied Research using OMIC Sciences SL Company Overview 104

5.20.1 Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview 104

5.21 Arizona State University Company Overview 105

5.21.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 105

5.22 ARK Diagnostics Inc Company Overview 106

5.22.1 ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.23 Augurix SA Company Overview 119

5.23.1 Augurix SA Pipeline Products & Ongoing Clinical Trials Overview 119

5.24 AutoGenomics Inc Company Overview 120

5.24.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.25 Avacta Group Plc Company Overview 121

5.25.1 Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview 121

5.26 Base Pair Biotechnologies Inc Company Overview 125

5.26.1 Base Pair Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 125

5.27 Becton Dickinson and Co Company Overview 126

5.27.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 126

5.28 BG Medicine Inc Company Overview 127

5.28.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 127

5.29 Biocross SL Company Overview 130

5.29.1 Biocross SL Pipeline Products & Ongoing Clinical Trials Overview 130

5.30 Bioftalmik Applied Research Company Overview 132

5.30.1 Bioftalmik Applied Research Pipeline Products & Ongoing Clinical Trials Overview 132

5.31 BIOHOPE Scientific SL Company Overview 133

5.31.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 133

5.32 BioMarin Pharmaceutical Inc Company Overview 134

5.32.1 BioMarin Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.33 Biotech Resources Aust Pty Ltd Company Overview 135

5.33.1 Biotech Resources Aust Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 135

5.34 Bisu Inc Company Overview 136

5.34.1 Bisu Inc Pipeline Products & Ongoing Clinical Trials Overview 136

5.35 Boditech Med Inc Company Overview 139

5.35.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.36 Boston University Company Overview 143

5.36.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 143

5.37 Burnet Institute Company Overview 144

5.37.1 Burnet Institute Pipeline Products & Ongoing Clinical Trials Overview 144

5.38 California Pacific Medical Center Research Institute Company Overview 145

5.38.1 California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview 145

5.39 Calmark Sweden AB Company Overview 146

5.39.1 Calmark Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 146

5.40 Cambridge Diagnostic Imaging Ltd Company Overview 149

5.40.1 Cambridge Diagnostic Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview 149

5.41 Carclo Diagnostic Solutions Ltd Company Overview 151

5.41.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 151

5.42 CardioGenics Inc Company Overview 153

5.42.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 153

5.43 CCC Diagnostics LLC Company Overview 154

5.43.1 CCC Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 154

5.44 Cellavision AB Company Overview 155

5.44.1 Cellavision AB Pipeline Products & Ongoing Clinical Trials Overview 155

5.45 Cellex Inc Company Overview 156

5.45.1 Cellex Inc Pipeline Products & Ongoing Clinical Trials Overview 156

5.46 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview 157

5.46.1 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 157

5.47 Centre Hospitalier Universitaire de Nice Company Overview 158

5.47.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 158

5.48 Charite University Hospital of Berlin Company Overview 159

5.48.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview 159

5.49 Chemeleon Inc Company Overview 160

5.49.1 Chemeleon Inc Pipeline Products & Ongoing Clinical Trials Overview 160

5.50 China Sky One Medical Inc Company Overview 161

5.50.1 China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 161

5.51 Chromanostics Inc Company Overview 162

5.51.1 Chromanostics Inc Pipeline Products & Ongoing Clinical Trials Overview 162

5.52 Chronix Biomedical Inc Company Overview 163

5.52.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 163

5.53 Claremont BioSolutions Company Overview 164

5.53.1 Claremont BioSolutions Pipeline Products & Ongoing Clinical Trials Overview 164

5.54 Clemson University Company Overview 165

5.54.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 165

5.55 Clinical Design Technologies Ltd Company Overview 166

5.55.1 Clinical Design Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 166

5.56 Cognizance Biomarkers LLC Company Overview 167

5.56.1 Cognizance Biomarkers LLC Pipeline Products & Ongoing Clinical Trials Overview 167

5.57 Columbia University Company Overview 168

5.57.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 168

5.58 ContraVac Inc (Inactive) Company Overview 171

5.58.1 ContraVac Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 171

5.59 CytoVas LLC Company Overview 172

5.59.1 CytoVas LLC Pipeline Products & Ongoing Clinical Trials Overview 172

5.60 Denovo Biolabs Pvt Ltd Company Overview 173

5.60.1 Denovo Biolabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 173

5.61 DiaSys Diagnostic Systems GmbH Company Overview 175

5.61.1 DiaSys Diagnostic Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 175

5.62 DNAPrint Genomics Inc (Inactive) Company Overview 176

5.62.1 DNAPrint Genomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 176

5.63 DoacLevel Company Overview 179

5.63.1 DoacLevel Pipeline Products & Ongoing Clinical Trials Overview 179

5.64 Dublin City University Company Overview 180

5.64.1 Dublin City University Pipeline Products & Ongoing Clinical Trials Overview 180

5.65 Ecole Polytechnique Federale de Lausanne Company Overview 181

5.65.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 181

5.66 Edan Instruments Inc Company Overview 182

5.66.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 182

5.67 EKF Diagnostics Holdings Plc Company Overview 183

5.67.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 183

5.68 ELITechGroup Inc Company Overview 184

5.68.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview 184

5.69 Eurobio Scientific SA Company Overview 189

5.69.1 Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 189

5.70 First Light Diagnostics Inc Company Overview 190

5.70.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 190

5.71 Fluoresprobe Sciences LLC Company Overview 191

5.71.1 Fluoresprobe Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 191

5.72 Foundation for Innovative New Diagnostics Company Overview 192

5.72.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 192

5.73 Gene Express, Inc. (Inactive) Company Overview 193

5.73.1 Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 193

5.74 GenMark Diagnostics Inc Company Overview 195

5.74.1 GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 195

5.75 Giner Inc Company Overview 197

5.75.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 197

5.76 GlucoSentient Inc Company Overview 198

5.76.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 198

5.77 Group K Diagnostics Company Overview 199

5.77.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 199

5.78 Guangzhou Wondfo Biotech Co Ltd Company Overview 202

5.78.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 202

5.79 Healthmed Services Ltd. (Inactive) Company Overview 208

5.79.1 Healthmed Services Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 208

5.80 Healthy io Ltd Company Overview 209

5.80.1 Healthy io Ltd Pipeline Products & Ongoing Clinical Trials Overview 209

5.81 Horiba Ltd Company Overview 211

5.81.1 Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview 211

5.82 Imperial College London Company Overview 213

5.82.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 213

5.83 Indian Institute of Technology Delhi Company Overview 216

5.83.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 216

5.84 Inflammatix Inc Company Overview 217

5.84.1 Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview 217

5.85 Insilixa, Inc. Company Overview 218

5.85.1 Insilixa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 218

5.86 Instrumentation Laboratory Co Company Overview 219

5.86.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview 219

5.87 IPI Singapore Company Overview 233

5.87.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 233

5.88 IR2Dx Inc. Company Overview 234

5.88.1 IR2Dx Inc. Pipeline Products & Ongoing Clinical Trials Overview 234

5.89 IRIS International Inc Company Overview 235

5.89.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 235

5.90 iXensor Co. Ltd. Company Overview 236

5.90.1 iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 236

5.91 Johns Hopkins University Company Overview 237

5.91.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 237

5.92 Kalium Health Ltd Company Overview 238

5.92.1 Kalium Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 238

5.93 KIYATEC Inc Company Overview 239

5.93.1 KIYATEC Inc Pipeline Products & Ongoing Clinical Trials Overview 239

5.94 Kobe University Company Overview 242

5.94.1 Kobe University Pipeline Products & Ongoing Clinical Trials Overview 242

5.95 Kwandong University College of Medicine Company Overview 243

5.95.1 Kwandong University College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 243

5.96 Laboratorios Rubio SA Company Overview 244

5.96.1 Laboratorios Rubio SA Pipeline Products & Ongoing Clinical Trials Overview 244

5.97 LifeAssays AB Company Overview 245

5.97.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 245

5.98 LumiraDx Ltd Company Overview 246

5.98.1 LumiraDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 246

5.99 Magee-Womens Research Institute Company Overview 247

5.99.1 Magee-Womens Research Institute Pipeline Products & Ongoing Clinical Trials Overview 247

5.100 Massachusetts Institute of Technology Company Overview 248

5.100.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 248

5.101 Medibio Ltd Company Overview 249

5.101.1 Medibio Ltd Pipeline Products & Ongoing Clinical Trials Overview 249

5.102 Medical Research Council Company Overview 252

5.102.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 252

5.103 Medical University of South Carolina Company Overview 253

5.103.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 253

5.104 Metabolon Inc Company Overview 254

5.104.1 Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 254

5.105 Miami VA Healthcare System Company Overview 256

5.105.1 Miami VA Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 256

5.106 MiCo BioMed Co Ltd Company Overview 257

5.106.1 MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 257

5.107 Monash University Company Overview 259

5.107.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 259

5.108 Montana State University Company Overview 261

5.108.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 261

5.109 Mylab Discovery Solutions Pvt Ltd Company Overview 262

5.109.1 Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 262

5.110 Myotherapeutics LLC (Inactive) Company Overview 263

5.110.1 Myotherapeutics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 263

5.111 NanoSpeed Diagnostics Inc Company Overview 264

5.111.1 NanoSpeed Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 264

5.112 Newcastle University Company Overview 265

5.112.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 265

5.113 Nipro Europe N.V. Company Overview 266

5.113.1 Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview 266

5.114 Northeastern University Company Overview 267

5.114.1 Northeastern University Pipeline Products & Ongoing Clinical Trials Overview 267

5.115 NTBIO Diagnostics Inc Company Overview 268

5.115.1 NTBIO Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 268

5.116 Nuclea Biotechnologies Inc. (Inactive) Company Overview 269

5.116.1 Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 269

5.117 Ohmx Corp Company Overview 271

5.117.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 271

5.118 OPKO Health Inc Company Overview 277

5.118.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 277

5.119 Overture Life Inc Company Overview 278

5.119.1 Overture Life Inc Pipeline Products & Ongoing Clinical Trials Overview 278

5.120 Oxford Immunotec Ltd Company Overview 281

5.120.1 Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview 281

5.121 Pax Neuroscience Inc Company Overview 282

5.121.1 Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 282

5.122 Pelago Bioscience AB Company Overview 283

5.122.1 Pelago Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview 283

5.123 Pennsylvania State University Company Overview 284

5.123.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 284

5.124 Plateletdiagnostics LLC Company Overview 287

5.124.1 Plateletdiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 287

5.125 PortaScience Inc Company Overview 288

5.125.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview 288

5.126 Prediction Sciences LLC (Inactive) Company Overview 289

5.126.1 Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 289

5.127 ProciseDx LLC Company Overview 291

5.127.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 291

5.128 Progenika Biopharma SA Company Overview 294

5.128.1 Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 294

5.129 PrognosDx Health Inc Company Overview 295

5.129.1 PrognosDx Health Inc Pipeline Products & Ongoing Clinical Trials Overview 295

5.130 Proteomika (Inactive) Company Overview 297

5.130.1 Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 297

5.131 Purdue University Company Overview 300

5.131.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 300

5.132 QSTAG Co Ltd Company Overview 301

5.132.1 QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 301

5.133 Queen Mary University of London Company Overview 303

5.133.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 303

5.134 Quidel Corp Company Overview 304

5.134.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 304

5.135 redhot diagnostics AB Company Overview 306

5.135.1 redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 306

5.136 Roche Diagnostics Corp Company Overview 307

5.136.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 307

5.137 Roche Diagnostics International Ltd Company Overview 308

5.137.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 308

5.138 Rockland Immunochemicals Inc Company Overview 329

5.138.1 Rockland Immunochemicals Inc Pipeline Products & Ongoing Clinical Trials Overview 329

5.139 SAGA Diagnostics AB Company Overview 330

5.139.1 SAGA Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 330

5.140 Saladax Biomedical Inc Company Overview 332

5.140.1 Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 332

5.141 SaltCheck Inc (Inactive) Company Overview 341

5.141.1 SaltCheck Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 341

5.142 Seattle Children’s Hospital Company Overview 342

5.142.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 342

5.143 Sebia SA Company Overview 344

5.143.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview 344

5.144 SenGenix Inc Company Overview 346

5.144.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 346

5.145 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 348

5.145.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 348

5.146 Siemens Healthcare Diagnostics Inc Company Overview 349

5.146.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 349

5.147 Sirius Genomics Inc Company Overview 355

5.147.1 Sirius Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 355

5.148 Spanish National Research Council Company Overview 356

5.148.1 Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 356

5.149 Specto Srl Company Overview 358

5.149.1 Specto Srl Pipeline Products & Ongoing Clinical Trials Overview 358

5.150 SQI Diagnostics Inc Company Overview 359

5.150.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 359

5.151 Stanford University Company Overview 361

5.151.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 361

5.152 SuperNova Diagnostics, Inc. Company Overview 362

5.152.1 SuperNova Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 362

5.153 Systagenix Wound Management Ltd Company Overview 363

5.153.1 Systagenix Wound Management Ltd Pipeline Products & Ongoing Clinical Trials Overview 363

5.154 T2 Biosystems Inc Company Overview 364

5.154.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 364

5.155 Teco Diagnostics Company Overview 365

5.155.1 Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 365

5.156 Testcard Diagnostics Ltd Company Overview 366

5.156.1 Testcard Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 366

5.157 The Chinese University of Hong Kong Company Overview 368

5.157.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 368

5.158 The University of New South Wales press Limited Company Overview 369

5.158.1 The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview 369

5.159 TheraDiag SA Company Overview 370

5.159.1 TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 370

5.160 Thermo Fisher Scientific Inc Company Overview 372

5.160.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 372

5.161 U.S. Army Medical Research and Development Command Company Overview 375

5.161.1 U.S. Army Medical Research and Development Command Pipeline Products & Ongoing Clinical Trials Overview 375

5.162 Universal Biosensors Inc Company Overview 376

5.162.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 376

5.163 Universidade Feevale Company Overview 377

5.163.1 Universidade Feevale Pipeline Products & Ongoing Clinical Trials Overview 377

5.164 University of Central Florida Company Overview 378

5.164.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 378

5.165 University of Colorado Company Overview 379

5.165.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 379

5.166 University of Colorado Denver Company Overview 381

5.166.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 381

5.167 University of Edinburgh Company Overview 382

5.167.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 382

5.168 University of Florida Company Overview 384

5.168.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 384

5.169 University of Illinois at Chicago Company Overview 385

5.169.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 385

5.170 University of Kentucky Company Overview 386

5.170.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview 386

5.171 University of Massachusetts Lowell Company Overview 387

5.171.1 University of Massachusetts Lowell Pipeline Products & Ongoing Clinical Trials Overview 387

5.172 University of North Carolina at Chapel Hill Company Overview 388

5.172.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 388

5.173 University of North Dakota Company Overview 389

5.173.1 University of North Dakota Pipeline Products & Ongoing Clinical Trials Overview 389

5.174 University of Queensland Company Overview 390

5.174.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 390

5.175 University of South Australia Company Overview 391

5.175.1 University of South Australia Pipeline Products & Ongoing Clinical Trials Overview 391

5.176 University of Texas at Arlington Company Overview 392

5.176.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 392

5.177 University of Washington Company Overview 393

5.177.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 393

5.178 UrSure Inc Company Overview 394

5.178.1 UrSure Inc Pipeline Products & Ongoing Clinical Trials Overview 394

5.179 Vanderbilt University Company Overview 398

5.179.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 398

5.180 Vanteres Pte Ltd Company Overview 399

5.180.1 Vanteres Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 399

5.181 Virginia Polytechnic Institute and State University Company Overview 400

5.181.1 Virginia Polytechnic Institute and State University Pipeline Products & Ongoing Clinical Trials Overview 400

5.182 Vyant Bio Inc Company Overview 401

5.182.1 Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 401

6 Clinical Chemistry- Recent Developments 402

6.1 Nov 16, 2022: International Isotopes Announces Financial Results for the Third Quarter and First Nine-months 2022 402

6.2 Nov 14, 2022: Ginkgo Bioworks Reports Third Quarter 2022 Financial Results 403

6.3 Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 403

6.4 Nov 11, 2022: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2022 405

6.5 Nov 09, 2022: Smiths Group reports strong start to FY 2023 405

6.6 Nov 09, 2022: Asahi Kasei announces Consolidated Results for 1st and 2nd Quarter Fiscal 2022 405

6.7 Nov 09, 2022: Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022 406

6.8 Nov 09, 2022: VolitionRx Limited Schedules Third Quarter 2022 Earnings Conference Call and Business Update 408

6.9 Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022 408

6.10 Nov 07, 2022: Techno Medica Non-consolidated Financial Results for the Six Months Ended September 30, 2022 410

6.11 Nov 03, 2022: Samsung Electronics appoints ex-trade minister as one of its 2 new outside directors 410

6.12 Nov 03, 2022: Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance 410

6.13 Nov 03, 2022: Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results 414

6.14 Nov 03, 2022: Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022 415

6.15 Nov 02, 2022: LumiraDx to Announce Third Quarter Financial Results and Host Quarterly Conference Call on November 9 417

6.16 Nov 01, 2022: Waters Corp Reports Third Quarter 2022 Financial Results 417

6.17 Nov 01, 2022: Aspira Women’s Health to Announce Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 10 419

6.18 Oct 31, 2022: Siemens appoints Hakan Ozdemir as CEO in Qatar 419

6.19 Oct 30, 2022: Siemens appoints Jamie Hoyzer as CEO in Oman 420

6.20 Oct 28, 2022: Tokuyama Announces Presentation for the Second Quarter Fiscal 2022 420

6.21 Oct 27, 2022: Samsung Electronics appoints Jay Lee as executive chairman 420

6.22 Oct 27, 2022: Bio-Rad Reports Third-Quarter 2022 Financial Results 420

6.23 Oct 26, 2022: BioMarin Announces Third Quarter 2022 Year-over-Year Total Revenue Growth of 24% 421

6.24 Oct 24, 2022: Cohere Health and Humana Expand Partnership to Further Improve Physician and Member Experiences 423

6.25 Oct 21, 2022: Biocartis Reports Results of Third Quarter of 2022 424

6.26 Oct 21, 2022: Olympus Announces Leadership Succession Plan 424

6.27 Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team 425

6.28 Oct 17, 2022: Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022 425

6.29 Oct 17, 2022: Illumina to Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022 425

6.30 Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022 426

6.31 Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring 426

6.32 Oct 13, 2022: Smiths Group announces Annual Financial Report 426

6.33 Oct 12, 2022: Gamma Biosciences and Lonza Collaborate to co-develop reagents for clinical cell selection in the cocoon platform 427

6.34 Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook 428

6.35 Oct 11, 2022: Omega Diagnostics Group Scientific Director to present at FIDHC 429

6.36 Oct 10, 2022: Creso Pharma accelerates company strategy with two new Director appointments, board transition and rebranding strategy to unlock additional M&A opportunities 429

6.37 Oct 07, 2022: BioMarin to lay off about 120 employees as part of restructuring plan 430

6.38 Sep 30, 2022: NetScientific announces Half-year Report 430

6.39 Sep 30, 2022: Eckard Eberle appointed as new CEO of Siemens Global Business Services 431

6.40 Sep 29, 2022: Avacta Group Announces Interim Results for the Period Ended 30 June 2022 432

6.41 Sep 27, 2022: Omega Diagnostics Group PLC Posting of Annual Report and confirmation of AGM 434

6.42 Sep 23, 2022: Smiths Group Full Year Results For 12 Months Ended 31 July 2022 434

6.43 Sep 23, 2022: Smiths Group announce Annual Results for the year ended 31 July 2022 435

6.44 Sep 19, 2022: Theradiag Announces Its Results for the First Half of 2022: Breaking-Even and Confirming Its Ability to Be Structurally Profitable From Early 2023 436

6.45 Sep 19, 2022: Illumina to Host Upcoming Investor Day 437

6.46 Sep 16, 2022: Svar Life Science Group Appoints Anne Thjømøe As New CEO 438

6.47 Sep 14, 2022: Horiba announces Review of First Half of 2022 439

6.48 Sep 12, 2022: VolitionRx to Webcast Live at VirtualInvestorConferences.com September 15th 439

6.49 Sep 12, 2022: VolitionRx to Webcast Live at VirtualInvestorConferences.com September 15th 439

6.50 Sep 08, 2022: Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference 440

6.51 Sep 08, 2022: MilliporeSigma announces investment of more than € 130 million to strengthen manufacturing capabilities in Molsheim, France 440

6.52 Sep 08, 2022: Toho pharmaceutical and Sysmex to Commence dry ice-free supply of quality control reagents for clinical chemistry tests 441

6.53 Sep 07, 2022: Amneal Appoints Gustavo Pesquin as Executive Vice President Chief Commercial Officer 442

6.54 Sep 06, 2022: QuantuMDx and Sansure partner to commercialise Q-POC platform in China 443

6.55 Sep 01, 2022: Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis 443

6.56 Sep 01, 2022: Ginkgo Bioworks appoints a veteran as its new SVP of biopharma manufacturing 444

6.57 Aug 31, 2022: Bristol Myers Squibb to Participate in Citi’s 17th Annual BioPharma Conference 444

6.58 Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer 444

6.59 Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results 445

6.60 Aug 25, 2022: Biocartis Announces 2022 Half-Year Results on 1 September 2022 446

6.61 Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference 446

6.62 Aug 24, 2022: New line of electrochemistry bench meters simplify pH, conductivity and dissolved oxygen measurement 446

6.63 Aug 23, 2022: Surmodics to Present at Upcoming

Frequently asked questions

Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more